Adverse Drug Reaction
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
HM
Hua MedicineChina - Shanghai
1 programPost-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World StudyN/A1 trial
Active Trials
Qilu PharmaceuticalChina - Jinan
1 programPost-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World StudyN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Hua MedicinePost-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Clinical Trials (1)
Total enrollment: 18,260 patients across 1 trials
NCT01946919Hua MedicinePost-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Start: Oct 2012Est. completion: Jun 202218,260 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space